Speakers
Rodrigo Garcia
Head of Clinical Innovation
EMD Serono
Day Two
Wednesday, December 9 2020
3:00 pm | 15.00 | 12.00 Panel Discussion – Exploring Technology Implementation Issues in Decentralized Trials
2:30 pm | 14.30 | 11.30 Addressing Internal Challenges to Set Up Your Decentralized Clinical Trial Journey
Jennifer Wulff
Director, Global Product Development
Pfizer
Day One
Tuesday, December 8 2020
12:20 pm | 12.20 | 9.20 The Current State of Decentralized Trials
9:30 am | 9.30 | 6.30 Panel Discussion – DCT Lessons Learned from Lockdown
Amir Lahav
Healthcare Intelligence and Digital Transformation Consultant
Mitsubishi Tanabe Pharma America
Day One
Tuesday, December 8 2020
9:30 am | 9.30 | 6.30 Panel Discussion – DCT Lessons Learned from Lockdown
9:00 am | 9.00 | 6.00 How to Continue Running Trials in Lockdown Using Decentralized Trials
Richard Erwin
Sr Director of Operations
Addario Lung Cancer Medical Institute
Gareth Powell
Business Development Officer
NIHR
Day One
Tuesday, December 8 2020
4:05 pm | 16.05 | 13.05 Fireside Chat – Discussing the Patient Experience of Decentralized Trials
Steven Cummings
Executive Director, S.F. Coordinating Center Prof. of Medicine, Epidemiology & Biostatistics
Sutter Health and UCSF
Day One
Tuesday, December 8 2020
2:50 pm | 14.50 | 11.50 Panel Discussion – Setting up Your Decentralized Trial for Success & Avoiding Crucial Mistakes
12:50 pm | 12.50 | 9.50 Factoring in All the Advantages & Limitations
Jimmy Bechtel
Director of Innovation & Engagement
Society for Clinical Research Sites
Day One
Tuesday, December 8 2020
4:35 pm | 16.35 | 13.35 Case Study - Using Patient-Centric Digital Tools in Decentralized Trials to Transform Clinical Research
Tom Switzer
Digital Health Scientist
Genentech
Day Two
Wednesday, December 9 2020
12:15 pm | 12.15 | 9.15 Panel Discussion – Challenges with Data: How to Maintain Data Quality & Integrity in a Decentralized Trial
10:45 am | 10.45 | 7.45 How to Determine if a Hybrid Trial is the Best Choice
10:00 am | 10.00 | 7.00 Panel Discussion - Are Hybrid Trials the True, Patient-Centric Trial?
Natalie Wilson
Business Development Manager
NIHR
Day Two
Wednesday, December 9 2020
11:15 am | 11.15 | 8.15 Forging Effective Partnerships When Using a Decentralized Format
10:00 am | 10.00 | 7.00 Panel Discussion - Are Hybrid Trials the True, Patient-Centric Trial?
Craig Lipset
Founder Clinical
Innovation Partners
Day One
Tuesday, December 8 2020
5:05 pm | 17.05 | 14.05 Chair’s Closing Remarks
11:50 am | 11.50 | 8.50 Personalization and the Future of the Decentralized Experience for Sites and Participants
9:30 am | 9.30 | 6.30 Panel Discussion – DCT Lessons Learned from Lockdown
Hassan Kadhim
Director, Head of Clinical Trial Business Capabilities
Bristol Myers Squibb
Day Two
Wednesday, December 9 2020
3:00 pm | 15.00 | 12.00 Panel Discussion – Exploring Technology Implementation Issues in Decentralized Trials
Kai Langel
Director, Clinical Innovation
Janssen
Day One
Tuesday, December 8 2020
2:15 pm | 14.15 | 11.15 Case Study: What is DEEP (Digital Endpoints Ecosystem & Protocols) and how will it help digital measures?
Day Two
Wednesday, December 9 2020
3:00 pm | 15.00 | 12.00 Panel Discussion – Exploring Technology Implementation Issues in Decentralized Trials
Esther Middleditch
International Clinical Program Leader
Roche
Joe Dustin
Head of Clinical Innovation
Bristol Myers Squibb
Day Two
Wednesday, December 9 2020
10:00 am | 10.00 | 7.00 Panel Discussion - Are Hybrid Trials the True, Patient-Centric Trial?
9:55 am | 9.55 | 6.55 Chair’s Opening Remarks
Shelly Barnes
Global Clinical Sciences & Operations
UCB
James Hacunda
R&D Digital Strategy Lead
Takeda
Day One
Tuesday, December 8 2020
9:30 am | 9.30 | 6.30 Panel Discussion – DCT Lessons Learned from Lockdown
Day Two
Wednesday, December 9 2020
1:00 pm | 13.00 | 10.00 The Space of Moving Imaging Technologies Complemented with AI Interpretation into a Decentralized or Home Environment
Tiffany McGinnis
Director US Site Management, DCT Strategic Lead
Bayer
Day One
Tuesday, December 8 2020
2:50 pm | 14.50 | 11.50 Panel Discussion – Setting up Your Decentralized Trial for Success & Avoiding Crucial Mistakes
Maria Fotiu
EVP, Decentralized Solutions
Syneos Health
Day One
Tuesday, December 8 2020
2:50 pm | 14.50 | 11.50 Panel Discussion – Setting up Your Decentralized Trial for Success & Avoiding Crucial Mistakes
Maimah Karmo
President/Founder
Tigerlily Foundation
Day One
Tuesday, December 8 2020
4:05 pm | 16.05 | 13.05 Fireside Chat – Discussing the Patient Experience of Decentralized Trials
Lauren Li
Head of Digital Health
Ipsen
Day Two
Wednesday, December 9 2020
10:00 am | 10.00 | 7.00 Panel Discussion - Are Hybrid Trials the True, Patient-Centric Trial?
Mohammed Ali
Global Head Digital Trials - Global Clinical Operation
Boehringer Ingelheim
Day Two
Wednesday, December 9 2020
10:00 am | 10.00 | 7.00 Panel Discussion - Are Hybrid Trials the True, Patient-Centric Trial?
Joy Bhosai
Chief of Digital Health & Strategy
Duke Clinical Research Institute
Amy Bohn
Study Operations Specialist, DCT
Bayer
Day Two
Wednesday, December 9 2020
3:00 pm | 15.00 | 12.00 Panel Discussion – Exploring Technology Implementation Issues in Decentralized Trials
Nadina Jose
CEO
NCJ Strategies
Day Two
Wednesday, December 9 2020
3:00 pm | 15.00 | 12.00 Panel Discussion – Exploring Technology Implementation Issues in Decentralized Trials
Len Rosenberg
Head of Clinical Operations
The Leukemia & Lymphoma Society
Day Two
Wednesday, December 9 2020
12:15 pm | 12.15 | 9.15 Panel Discussion – Challenges with Data: How to Maintain Data Quality & Integrity in a Decentralized Trial
Christina Fawcett
Senior Director of Operations, Real World Solutions, Digital Health
PRA Health Sciences
Day One
Tuesday, December 8 2020
10:15 am | 10.15 | 7.15 On The Cusp of COVID-19: How A Decentralized Clinical Trial Stayed The Course in The Midst of The Pandemic
Isaac Rodriguez-Chavez
SVP Scientific & Clinical Affairs
PRA Health Sciences
Day One
Tuesday, December 8 2020